(18)F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study

E.H. Elzinga; J. van der Laken; E.F.I. Comans; R. Boellaard; O.S. Hoekstra; B.A.C. Dijkmans; A.A. Lammertsma; A.E. Voskuyl

doi:10.2967/jnumed.110.076711

(18)F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study

E.H. Elzinga, J. van der Laken, E.F.I. Comans, R. Boellaard, O.S. Hoekstra, B.A.C. Dijkmans, A.A. Lammertsma, A.E. Voskuyl

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	77-80
Journal	Journal of Nuclear Medicine
Volume	52
Issue number	1
DOIs	https://doi.org/10.2967/jnumed.110.076711
Publication status	Published - 2011

Access to Document

10.2967/jnumed.110.076711

Cite this

@article{9bc02ffff678479cb5e9505797f9738a,

title = "(18)F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study",

author = "E.H. Elzinga and {van der Laken}, J. and E.F.I. Comans and R. Boellaard and O.S. Hoekstra and B.A.C. Dijkmans and A.A. Lammertsma and A.E. Voskuyl",

year = "2011",

doi = "10.2967/jnumed.110.076711",

language = "Undefined/Unknown",

volume = "52",

pages = "77--80",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "1",

}

TY - JOUR

T1 - (18)F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study

AU - Elzinga, E.H.

AU - van der Laken, J.

AU - Comans, E.F.I.

AU - Boellaard, R.

AU - Hoekstra, O.S.

AU - Dijkmans, B.A.C.

AU - Lammertsma, A.A.

AU - Voskuyl, A.E.

PY - 2011

Y1 - 2011

U2 - 10.2967/jnumed.110.076711

DO - 10.2967/jnumed.110.076711

M3 - Article

C2 - 21149486

SN - 0161-5505

VL - 52

SP - 77

EP - 80

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 1

ER -